Investing.com - Financial Markets Worldwide

AstraZeneca issues 67,907 shares under employee share plans in latest period

Published 01/12/2025, 17:56
© Reuters.
AZN
-0.26%
AZN
-0.13%

AstraZeneca PLC (NASDAQ:AZN) reported Monday that it issued 67,907 ordinary shares under its employee share plans during the six-month period from June 1 to November 30, 2025. The information was disclosed in a press release statement based on a filing with the U.S. Securities and Exchange Commission.

According to the filing, the shares were issued under several schemes, including the AstraZeneca Share Option Plan, Savings-Related Share Option Plan, All-Employee Share Plan, and the 2012 Savings-Related Share Option Scheme.

At the beginning of the period, AstraZeneca had a balance of 3,688,383 unallotted shares under these schemes. No additional shares were added to the block listing during the period. After issuing the 67,907 shares, the balance of unallotted shares under the schemes at the end of the period was 3,620,476.

The filing was signed by Matthew Bowden, Company Secretary. AstraZeneca is listed on the London Stock Exchange, Stockholm Stock Exchange, and NASDAQ.

All information is based on a press release statement and the company’s SEC filing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.